# Application of 68Ga-NODAGA-SNA006 Positron Emission Tomography/Computed Tomography (PET/CT) in Tumors

> **NCT07059832** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **First Hospital of China Medical University** · enrollment: 30 (estimated)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** 68Ga-NODAGA-SNA006

## Key facts

- **NCT ID:** NCT07059832
- **Lead sponsor:** First Hospital of China Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-04-01
- **Primary completion:** 2028-01-01
- **Final completion:** 2028-04-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07059832

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07059832, "Application of 68Ga-NODAGA-SNA006 Positron Emission Tomography/Computed Tomography (PET/CT) in Tumors". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07059832. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*